Derivatives: Adjustment in Karo Pharma due to rights issue (25/17)


The Extraordinary General Meeting (EGM) of Karo Pharma AB (Karo Pharma) held on December 8, 2017 approved a rights issue whereby shareholders are entitled to one (1) new share for every tree (3) shares held. The subscription price is SEK 29.00 per share. The Ex-date is December 12, 2017. NASDAQ Derivatives Markets has carried out a re-calculation of options, forwards and futures in Karo Pharma (KAROB).

For further information please find the attached file.


Attachments

25_Karo_Pharma_rights_issue_2.pdf